These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29226723)
1. Pen devices for self-injection: contrasting measured injection force with users' perceived ease of injection. Schneider AE; Lange J Expert Opin Drug Deliv; 2018 Feb; 15(2):115-125. PubMed ID: 29226723 [TBL] [Abstract][Full Text] [Related]
2. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Clark PE; Valentine V; Bodie JN; Sarwat S Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243 [TBL] [Abstract][Full Text] [Related]
3. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads. Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739 [TBL] [Abstract][Full Text] [Related]
4. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning. Nadeau DA; Campos C; Niemeyer M; Bailey T Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905 [TBL] [Abstract][Full Text] [Related]
5. Quantifying Patient Capabilities and Setting the Stage for Future Development: Insights from a Sensor-Augmented Simulated Use Study with Pen Injectors. Lange J; Schneider AE; Jordi C Med Devices (Auckl); 2024; 17():271-283. PubMed ID: 39099757 [TBL] [Abstract][Full Text] [Related]
6. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Ignaut DA; Schwartz SL; Sarwat S; Murphy HL Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767 [TBL] [Abstract][Full Text] [Related]
7. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study. Haak T; Edelman S; Walter C; Lecointre B; Spollett G Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288 [TBL] [Abstract][Full Text] [Related]
8. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes. Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585 [TBL] [Abstract][Full Text] [Related]
9. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes. Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497 [TBL] [Abstract][Full Text] [Related]
10. Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus. Schipper C; Musholt P; Niemeyer M; Qvist M; Löffler A; Forst T; Pfützner A Curr Med Res Opin; 2012 Aug; 28(8):1297-303. PubMed ID: 22746353 [TBL] [Abstract][Full Text] [Related]
11. Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates. van der Burg T J Diabetes Sci Technol; 2011 Jan; 5(1):150-5. PubMed ID: 21303637 [TBL] [Abstract][Full Text] [Related]
12. Comparison of clinically relevant technical attributes of five insulin injection pens. Asakura T J Diabetes Sci Technol; 2011 Sep; 5(5):1203-9. PubMed ID: 22027319 [TBL] [Abstract][Full Text] [Related]
13. Preference for insulin delivery systems among current insulin users and nonusers. Summers KH; Szeinbach SL; Lenox SM Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012 [TBL] [Abstract][Full Text] [Related]
14. What can we learn from patient-reported outcomes of insulin pen devices? Anderson BJ; Redondo MJ J Diabetes Sci Technol; 2011 Nov; 5(6):1563-71. PubMed ID: 22226279 [TBL] [Abstract][Full Text] [Related]
15. FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Gudiksen N; Hofstätter T; Rønn BB; Sparre T Diabetes Technol Ther; 2017 Oct; 19(10):603-607. PubMed ID: 28704062 [TBL] [Abstract][Full Text] [Related]
16. Overview of insulin delivery pen devices. Kroon L J Am Pharm Assoc (2003); 2009; 49(5):e118-31. PubMed ID: 19692314 [TBL] [Abstract][Full Text] [Related]
17. Development of the SoloSTAR insulin pen device: design verification and validation. Bode A Expert Opin Drug Deliv; 2009 Jan; 6(1):103-12. PubMed ID: 19236211 [TBL] [Abstract][Full Text] [Related]
18. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals. Bailey T; Campos C Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783 [TBL] [Abstract][Full Text] [Related]
19. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals. Pfützner A; Forst T; Niemeyer M; Bailey T Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223 [TBL] [Abstract][Full Text] [Related]
20. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. Molife C; Lee LJ; Shi L; Sawhney M; Lenox SM Diabetes Technol Ther; 2009 Aug; 11(8):529-38. PubMed ID: 19698067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]